Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 5Active not recruiting 2Enrolling by invitation 1Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Breast Neoplasms 51Neoplasms 45Colorectal Neoplasms 27Carcinoma, Non-Small-Cell Lung 22Prostatic Neoplasms 20Lung Neoplasms 16Leukemia, Myeloid, Acute 16Recurrence 12Multiple Myeloma 11Melanoma 11Stomach Neoplasms 10Head and Neck Neoplasms 10Ovarian Neoplasms 9Uterine Cervical Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Precursor Cell Lymphoblastic Leukemia-Lymphoma 8Lymphoma, Non-Hodgkin 8Pancreatic Neoplasms 7Neoplasm Metastasis 7Myelodysplastic Syndromes 7Lymphoma 7Glioma 7Carcinoma, Renal Cell 7Brain Neoplasms 7Motor Activity 6Leukemia 6Hodgkin Disease 6Esophageal Neoplasms 6Colonic Neoplasms 6Carcinoma, Hepatocellular 6

Interventions

Prednisone 1Docetaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Prostatic Neoplasms, Castration-Resistant × 30 days × Clear all
NCT05848011 2026-05-22

A Study of Lorigerlimab With Docetaxel or Docetaxel Alone in Participants With Metastatic Castration-Resistant Prostate Cancer

MacroGenics

Phase 2 Completed
154 enrolled
Genitourinary

Prostatic Neoplasms, Castration-Resistant

Data powered by HemOnc (CC BY 4.0) Colophon âš¡